← Back

UK MHRA · UK · 31 Mar 2026 · Guidance

Guidance: Approving clinical investigations

From UK MHRA

We aim to process applications in the shortest time possible, while ensuring that any risk to the patient and user is minimised and the investigation is justified by the potential benefit to the participants in the proposed clinical investigation.

This guidance explains our processes and timetables for clinical investigations in Great Britain and Northern Ireland.

Excerpt from the official page. The original is authoritative.